{"id":"https://openalex.org/W1998287201","doi":"https://doi.org/10.1007/s00228-008-0605-4","title":"Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers","display_name":"Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers","publication_year":2009,"publication_date":"2009-01-15","ids":{"openalex":"https://openalex.org/W1998287201","doi":"https://doi.org/10.1007/s00228-008-0605-4","mag":"1998287201","pmid":"https://pubmed.ncbi.nlm.nih.gov/19148629"},"language":"en","primary_location":{"id":"doi:10.1007/s00228-008-0605-4","doi":"https://doi.org/10.1007/s00228-008-0605-4","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00228-008-0605-4","pdf_url":null,"source":{"id":"https://openalex.org/S31780008","display_name":"European Journal of Clinical Pharmacology","issn_l":"0031-6970","issn":["0031-6970","1432-1041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060450049","display_name":"Antonio Rusca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267631","display_name":"CROSS Research SA (Switzerland)","ror":"https://ror.org/03nqjwm69","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267631"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Antonio Rusca","raw_affiliation_strings":["Cross Research S.A., via F. A. Giorgioli, Arzo, Switzerland","Cross Research S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cross Research S.A., via F. A. Giorgioli, Arzo, Switzerland","institution_ids":["https://openalex.org/I4405267631"]},{"raw_affiliation_string":"Cross Research S.A","institution_ids":["https://openalex.org/I4405267631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039418277","display_name":"Andrea F. D. Di Stefano","orcid":"https://orcid.org/0000-0002-4316-9039","observed_orcids":["https://orcid.org/0000-0002-4316-9039"]},"institutions":[{"id":"https://openalex.org/I4405267631","display_name":"CROSS Research SA (Switzerland)","ror":"https://ror.org/03nqjwm69","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267631"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Andrea Francesco Daniele Di Stefano","raw_affiliation_strings":["Cross Research S.A., via F. A. Giorgioli, Arzo, Switzerland","Cross Research S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cross Research S.A., via F. A. Giorgioli, Arzo, Switzerland","institution_ids":["https://openalex.org/I4405267631"]},{"raw_affiliation_string":"Cross Research S.A","institution_ids":["https://openalex.org/I4405267631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091836930","display_name":"Mira V. Doig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099795","display_name":"American Bureau of Shipping","ror":"https://ror.org/00zv9q339","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210099795"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mira V. Doig","raw_affiliation_strings":["ABS Laboratories Ltd., Wardalls Grove, Avonley Road, London, SE14 5ER, UK","ABS Laboratories Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ABS Laboratories Ltd., Wardalls Grove, Avonley Road, London, SE14 5ER, UK","institution_ids":["https://openalex.org/I4210099795"]},{"raw_affiliation_string":"ABS Laboratories Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058969258","display_name":"Claudia Scarsi","orcid":"https://orcid.org/0009-0000-8517-2343","observed_orcids":["https://orcid.org/0009-0000-8517-2343"]},"institutions":[{"id":"https://openalex.org/I4210152331","display_name":"IBSA Institut Biochimique (Switzerland)","ror":"https://ror.org/051tj3a26","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210152331"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Claudia Scarsi","raw_affiliation_strings":["IBSA, Institut Biochimique SA, Via del Piano, P.O. Box 266, CH-6915, Pambio-Noranco, Switzerland","IBSA, Institut Biochimique SA, Pambio-Noranco, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IBSA, Institut Biochimique SA, Via del Piano, P.O. Box 266, CH-6915, Pambio-Noranco, Switzerland","institution_ids":["https://openalex.org/I4210152331"]},{"raw_affiliation_string":"IBSA, Institut Biochimique SA, Pambio-Noranco, Switzerland","institution_ids":["https://openalex.org/I4210152331"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040883137","display_name":"Emilio Perucca","orcid":"https://orcid.org/0000-0001-8703-223X","observed_orcids":["https://orcid.org/0000-0001-8703-223X","https://orcid.org/0000-0003-3232-1389"]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]},{"id":"https://openalex.org/I4210095701","display_name":"Fondazione Istituto Neurologico Nazionale Casimiro Mondino","ror":"https://ror.org/009h0v784","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210095701","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emilio Perucca","raw_affiliation_strings":["Institute of Neurology, IRCCS C. Mondino Foundation and Clinical Pharmacology Unit, University of Pavia, Pavia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Neurology, IRCCS C. Mondino Foundation and Clinical Pharmacology Unit, University of Pavia, Pavia, Italy","institution_ids":["https://openalex.org/I25217355","https://openalex.org/I4210095701"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5058969258"],"corresponding_institution_ids":["https://openalex.org/I4210152331"],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":null,"fwci":5.732,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.95416885,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"65","issue":"5","first_page":"503","last_page":"510"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10450","display_name":"Aquaculture Nutrition and Growth","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1104","display_name":"Aquatic Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/docosahexaenoic-acid","display_name":"docosahexaenoic acid","score":0.9990000128746033},{"id":"https://openalex.org/keywords/eicosapentaenoic-acid","display_name":"eicosapentaenoic acid","score":1.0},{"id":"https://openalex.org/keywords/omega-3-fatty-acids","display_name":"omega-3 fatty acids","score":0.9190000295639038},{"id":"https://openalex.org/keywords/oral-formulations","display_name":"oral dosage forms","score":0.6349999904632568},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.9580000042915344},{"id":"https://openalex.org/keywords/relative-bioavailability","display_name":"relative bioavailability","score":0.9319999814033508},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9430000185966492},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.9649999737739563},{"id":"https://openalex.org/keywords/steady-state-plasma-concentration","display_name":"steady-state plasma concentration","score":0.8009999990463257},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.8746324181556702},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.8620986938476562},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8275147676467896},{"id":"https://openalex.org/C2776091944","wikidata":"https://www.wikidata.org/wiki/Q409990","display_name":"Eicosapentaenoic acid","level":4,"score":0.8195444345474243},{"id":"https://openalex.org/C2777171753","wikidata":"https://www.wikidata.org/wiki/Q423345","display_name":"Docosahexaenoic acid","level":4,"score":0.712639331817627},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6575440168380737},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.6207680106163025},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5005381107330322},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33923909068107605},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3235268294811249},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.232343852519989},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.22640272974967957},{"id":"https://openalex.org/C19038510","wikidata":"https://www.wikidata.org/wiki/Q2005087","display_name":"Polyunsaturated fatty acid","level":3,"score":0.11139515042304993},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10082671046257019}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002214","descriptor_name":"Capsules","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004281","descriptor_name":"Docosahexaenoic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004281","descriptor_name":"Docosahexaenoic Acids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004281","descriptor_name":"Docosahexaenoic Acids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015525","descriptor_name":"Fatty Acids, Omega-3","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015525","descriptor_name":"Fatty Acids, Omega-3","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015525","descriptor_name":"Fatty Acids, Omega-3","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00228-008-0605-4","doi":"https://doi.org/10.1007/s00228-008-0605-4","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00228-008-0605-4","pdf_url":null,"source":{"id":"https://openalex.org/S31780008","display_name":"European Journal of Clinical Pharmacology","issn_l":"0031-6970","issn":["0031-6970","1432-1041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:19148629","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19148629","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W46749387","https://openalex.org/W71576337","https://openalex.org/W87870904","https://openalex.org/W1516865785","https://openalex.org/W1850077490","https://openalex.org/W1973420334","https://openalex.org/W1979122474","https://openalex.org/W1983531379","https://openalex.org/W1986551149","https://openalex.org/W2014696483","https://openalex.org/W2031731414","https://openalex.org/W2042812958","https://openalex.org/W2047504901","https://openalex.org/W2065552442","https://openalex.org/W2087858694","https://openalex.org/W2101513524","https://openalex.org/W2104285446","https://openalex.org/W2110666050","https://openalex.org/W2122074593","https://openalex.org/W2124138679","https://openalex.org/W2141885792","https://openalex.org/W2145492067","https://openalex.org/W2160681814","https://openalex.org/W2192223169","https://openalex.org/W2323818785","https://openalex.org/W2345098798","https://openalex.org/W2477025387","https://openalex.org/W4250374921","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W4389558579","https://openalex.org/W2889687534","https://openalex.org/W4378673895","https://openalex.org/W2414177064","https://openalex.org/W2042812958","https://openalex.org/W4404705357","https://openalex.org/W2076227453","https://openalex.org/W2901822462","https://openalex.org/W4402630999","https://openalex.org/W2017776734"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}